CN100399029C - 蛋白质同种型的测定 - Google Patents

蛋白质同种型的测定 Download PDF

Info

Publication number
CN100399029C
CN100399029C CNB200480009126XA CN200480009126A CN100399029C CN 100399029 C CN100399029 C CN 100399029C CN B200480009126X A CNB200480009126X A CN B200480009126XA CN 200480009126 A CN200480009126 A CN 200480009126A CN 100399029 C CN100399029 C CN 100399029C
Authority
CN
China
Prior art keywords
protein
fragment
specific binding
kit according
binding partner
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB200480009126XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1768269A (zh
Inventor
菲利普·D·赖伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axis Shield ASA
Original Assignee
Axis Shield ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axis Shield ASA filed Critical Axis Shield ASA
Publication of CN1768269A publication Critical patent/CN1768269A/zh
Application granted granted Critical
Publication of CN100399029C publication Critical patent/CN100399029C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CNB200480009126XA 2003-02-06 2004-02-06 蛋白质同种型的测定 Expired - Fee Related CN100399029C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0302740.6A GB0302740D0 (en) 2003-02-06 2003-02-06 Assay
GB0302740.6 2003-02-06

Publications (2)

Publication Number Publication Date
CN1768269A CN1768269A (zh) 2006-05-03
CN100399029C true CN100399029C (zh) 2008-07-02

Family

ID=9952561

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB200480009126XA Expired - Fee Related CN100399029C (zh) 2003-02-06 2004-02-06 蛋白质同种型的测定

Country Status (9)

Country Link
US (1) US20060216766A1 (https=)
EP (1) EP1590675A1 (https=)
JP (1) JP2006517664A (https=)
CN (1) CN100399029C (https=)
AU (1) AU2004209876B2 (https=)
CA (1) CA2515148A1 (https=)
GB (1) GB0302740D0 (https=)
NO (1) NO20053990L (https=)
WO (1) WO2004070389A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7476546B2 (en) 2004-11-15 2009-01-13 University Of North Dakota Method for single oxygen atom incorporation into digested peptides using peptidases
WO2013071127A1 (en) * 2011-11-09 2013-05-16 Alper Biotech, Llc Monoclonal antibodies against serotransferrin antigens, and uses therefor
JP6500397B2 (ja) 2013-12-25 2019-04-17 東ソー株式会社 Ｎ型糖鎖が付加している部位又はその割合の測定方法
EP3571509B1 (en) 2017-01-18 2023-05-10 Sartorius BioAnalytical Instruments, Inc. Methods and reagents for determining immunoglobulin gamma (igg) antibody isotype concentration from biological samples
CN114078568B (zh) * 2020-09-14 2022-07-05 青岛欧易生物科技有限公司 基于iib型限制性内切酶特征的宏基因组测序数据处理系统及处理方法
CN117169519B (zh) * 2023-10-26 2024-01-30 艾康生物技术(杭州)有限公司 用于检测样本中tt3和/或tt4的解离剂和试剂盒

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1142855A (zh) * 1993-12-08 1997-02-12 T细胞科学公司 人源化抗体及其用途
US5631140A (en) * 1994-07-18 1997-05-20 Boehringer Mannheim Gmbh Method for the quantitative determination of glycated proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0212391D0 (en) * 2002-05-29 2002-07-10 Axis Shield Asa Assay
EP1514107B1 (en) * 2002-06-03 2013-05-15 The Institute for Systems Biology Methods for quantitative proteome analysis of glycoproteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1142855A (zh) * 1993-12-08 1997-02-12 T细胞科学公司 人源化抗体及其用途
US5631140A (en) * 1994-07-18 1997-05-20 Boehringer Mannheim Gmbh Method for the quantitative determination of glycated proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Characterization of Human Cleaved N-CAMand Associationwith Schizophrenia. Vawter Marquis P et al.Experimental Neurology,Vol.172 No.1. 2001 *
Indentification of Alphal-antitrypsin VariantsinPlasmawiththeuse of Proteomic Technology. Mills Kevin et al.Clinical Chemistry,Vol.47 No.11. 2001 *
Structural Studies on Equine GycoproteinHormonesAminoacidsequence of Equine ChorionicGonadotropinBeta-subunit. Sugino H et al.Journal of Biological Chemistry,Vol.262 No.18. 1987 *

Also Published As

Publication number Publication date
AU2004209876B2 (en) 2007-10-11
WO2004070389A1 (en) 2004-08-19
EP1590675A1 (en) 2005-11-02
AU2004209876A1 (en) 2004-08-19
CA2515148A1 (en) 2004-08-19
US20060216766A1 (en) 2006-09-28
WO2004070389A8 (en) 2004-12-02
JP2006517664A (ja) 2006-07-27
GB0302740D0 (en) 2003-03-12
NO20053990L (no) 2005-08-26
CN1768269A (zh) 2006-05-03

Similar Documents

Publication Publication Date Title
US9541549B2 (en) Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determination
US9470686B2 (en) Combination hepatitis C virus antigen and antibody detection method
US11255855B1 (en) COVID-19 spike-ACE2 binding assay for drug and antibody screening
PT742438E (pt) Rastreio de bibliotecas combinatórias de péptidos para a selecção de ligandos de péptidos úteis na purificação por afinidade de proteínas-alvo
CA2522709A1 (en) Polypeptides related to natriuretic peptides and methods of their identification and use
RU2009143671A (ru) Высокочувствительные иммуноанализы и наборы для определения представляющих интерес пептидов и белков
TW202311744A (zh) SARS-CoV-2之免疫測定方法及免疫測定套組
EP1328811B1 (en) Hcv mosaic antigen composition
TW202307432A (zh) SARS-CoV-2之免疫測定方法及免疫測定套組、以及單株抗體或其之抗體片段
CN104142404A (zh) 检测人gfap蛋白的荧光免疫层析试纸及其制备方法
JP2009531679A (ja) 複合タンパク質混合物中の被分析タンパク質および／または被分析ペプチドを検出および／または増幅するための方法
CN109425598A (zh) 一种毛细自驱动微流控芯片及其制备方法与应用
KR20120125157A (ko) 렉틴을 이용한 암 진단 방법
CN100399029C (zh) 蛋白质同种型的测定
US7842456B2 (en) Reagents, kits and methods for immunodetection of epitopes on molecules
US20040106146A1 (en) Immunochemical methods
JP2009162535A (ja) 固相作製用試薬及び該試薬を使用して作製した固相
CN116223796A (zh) 病毒联合检测免疫层析试纸、检测笔和检测产品
US7094551B2 (en) Immunoassays, assay methods, antibodies and method of creating antibodies for detecting FGF-23
KR102105157B1 (ko) 펩신에 의해 특이적으로 분해되는 펩타이드 및 이를 포함하는 역류성 인후두염 진단용 키트
KR102131860B1 (ko) 아르기닌이 메틸화된 ggt1에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
JPH08285853A (ja) コリンエステラーゼの測定法及び肝硬変と肝炎の識別法
CN118910066A (zh) 一种检测肿瘤标志物afp的核酸适配体及侧向层析试纸条
FI104376B (fi) Hb A1c:lle spesifisiä monoklonaalisia vasta-aineita
CN115201465A (zh) 基于多肽芯片的抗体特异性结合的多肽的筛选方法及其筛选的多肽的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080702

Termination date: 20100206